150 related articles for article (PubMed ID: 15821189)
1. Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival.
Duchateau CS; Stokkel MP
Chest; 2005 Apr; 127(4):1152-8. PubMed ID: 15821189
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer as a second primary malignancy: increasing prevalence and its influence on survival.
Quadrelli S; Lyons G; Colt H; Chimondeguy D; Silva C
Ann Surg Oncol; 2009 Apr; 16(4):1033-8. PubMed ID: 19190966
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
Yi SZ; Zhang DC; Wang YG; Sun KL
Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
[TBL] [Abstract][Full Text] [Related]
4. Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer.
Fink-Neuboeck N; Lindenmann J; Porubsky C; Fediuk M; Anegg U; Maier A; Smolle J; Lamont E; Smolle-Juettner FM
Clin Lung Cancer; 2020 Jul; 21(4):333-340. PubMed ID: 32273257
[TBL] [Abstract][Full Text] [Related]
5. Survival in patients with metachronous second primary lung cancer.
Ha D; Choi H; Chevalier C; Zell K; Wang XF; Mazzone PJ
Ann Am Thorac Soc; 2015 Jan; 12(1):79-84. PubMed ID: 25494009
[TBL] [Abstract][Full Text] [Related]
6. Analysis of second primary lung cancers in the SEER database.
Bhaskarla A; Tang PC; Mashtare T; Nwogu CE; Demmy TL; Adjei AA; Reid ME; Yendamuri S
J Surg Res; 2010 Jul; 162(1):1-6. PubMed ID: 20400118
[TBL] [Abstract][Full Text] [Related]
7. History of multiple previous malignancies should not be a contraindication to the surgical resection of lung cancer.
Pagès PB; Mordant P; Grand B; Badia A; Foucault C; Dujon A; Le Pimpec-Barthes F; Riquet M
Ann Thorac Surg; 2013 Mar; 95(3):1000-5. PubMed ID: 23375734
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.
Hamaji M; Allen MS; Cassivi SD; Deschamps C; Nichols FC; Wigle DA; Shen KR
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):683-90; discussion 690-1. PubMed ID: 23414986
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes of non-small-cell lung carcinoma in patients previously treated for gastric cancer.
Tsubokawa N; Mimae T; Aokage K; Hattori A; Suzuki K; Nagai K; Tsuboi M; Okada M
Eur J Cardiothorac Surg; 2015 Apr; 47(4):648-52. PubMed ID: 24980557
[TBL] [Abstract][Full Text] [Related]
10. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years.
Johnson BE; Linnoila RI; Williams JP; Venzon DJ; Okunieff P; Anderson GB; Richardson GE
J Clin Oncol; 1995 Jan; 13(1):101-11. PubMed ID: 7799009
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of lung cancer resection in patients with previous extra-respiratory solid malignancies.
Pagès PB; Mordant P; Cazes A; Grand B; Foucault C; Dujon A; Le Pimpec Barthes F; Riquet M
Eur J Cardiothorac Surg; 2013 Sep; 44(3):534-8. PubMed ID: 23392106
[TBL] [Abstract][Full Text] [Related]
12. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
13. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
Bryant A; Cerfolio RJ
Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of lung cancer after a previous malignancy.
Reinmuth N; Stumpf P; Stumpf A; Muley T; Kobinger S; Hoffmann H; Herth FJ; Schnabel PA; Bischoff H; Thomas M
Respir Med; 2014 Jun; 108(6):910-7. PubMed ID: 24650574
[TBL] [Abstract][Full Text] [Related]
15. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
16. Urological implications of concurrent bladder and lung cancer.
Vainrib M; Leibovitch I
Isr Med Assoc J; 2007 Oct; 9(10):732-5. PubMed ID: 17987763
[TBL] [Abstract][Full Text] [Related]
17. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
Liao ML; Zhou YZ; Ding JA; Ni GX; Zhao JM; Chen WH; Han BH; Shen J; Bai H; Chen ZW; Ji H; Wang HM; Zhou Z
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):962-6. PubMed ID: 12899797
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome in lung cancer with a second malignancy: The time sequence matters.
Lu MS; Chen MF; Huang YK; Liu HP; Tsai YH
Medicine (Baltimore); 2016 Oct; 95(43):e5203. PubMed ID: 27787376
[TBL] [Abstract][Full Text] [Related]
19. Survival in second primary malignancies of patients with head and neck cancer.
Di Martino E; Sellhaus B; Hausmann R; Minkenberg R; Lohmann M; Esthofen MW
J Laryngol Otol; 2002 Oct; 116(10):831-8. PubMed ID: 12437840
[TBL] [Abstract][Full Text] [Related]
20. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
